Orsobio

Developer of therapeutics for multiple metabolic diseases

placePalo Alto, California, United States calendar_todayFounded 2021 groups10 employees language orsobio.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 628 times.

YearFilings
20222
20233
20244
20256
20262

Social engagement

Social engagement: 3.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Longitude Capital, Enavate Sciences, Ascenta Capital.

Investor typeCountShare
Venture capital338%
Private equity113%
Other / undisclosed450%

Recent activity

22 Jun 2026
Event
BIO 2026
Coming soon